Roscovitine, an inhibitor of CDK5 with additional immunosuppressive effects reduced neuronal loss, glial activation, as well as microglia proliferation, NO release, and neurologic deficits after brain trauma or stroke (Di Giovanni et al., 2005; Hilton et al., 2008; Menn et al., 2010). Here, CDK5 is linked to Stroke.